Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Recent Updates

Go back to Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Recent Updates
(NASDAQ: ANEB) Delayed: 0.36 --0 (-0%)
Previous Close $0.36    52 Week High
Open $0.36    52 Week Low
Day High $0.36    P/E N/A 
Day Low $0.36    EPS
Volume 85